Certara Inc.

27.53-0.5300-1.89%Vol 110.86K1Y Perf -27.40%
Apr 19th, 2021 12:17 DELAYED
BID27.43 ASK27.59
Open27.73 Previous Close28.06
Pre-Market- After-Market-
 - -%  - -
Target Price
36.00 
Analyst Rating
— — 0.00
Potential %
30.25 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     47.33
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     51.69
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap4.21B 
Earnings Rating
Price Range Ratio 52W %
17.14 
Earnings Date
3rd Jun 2021

Today's Price Range

27.3028.42

52W Range

24.5841.79

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
4.08%
1 Month
-10.95%
3 Months
-
6 Months
-
1 Year
-27.40%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CERT27.53-0.5300-1.89
AAPL134.420.26000.19
GOOG2 300.062.30000.10
MSFT258.83-1.9100-0.73
XOM56.27-0.3900-0.69
WFC43.970.13000.30
JNJ162.880.64000.39
FB302.50-3.6800-1.20
GE13.36-0.0300-0.22
JPM153.16-0.1400-0.09
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.42-0.3711.90
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date3rd Jun 2021
Estimated EPS Next Report0.04
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume110.86K
Shares Outstanding152.98M
Trades Count880
Dollar Volume11.75M
Avg. Volume639.52K
Avg. Weekly Volume206.24K
Avg. Monthly Volume784.64K
Avg. Quarterly Volume649.69K

Certara Inc. (NASDAQ: CERT) stock closed at 28.06 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 291.78K shares and market capitalization of 4.21B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 899 people. Certara Inc. CEO is William F. Feehery.

The one-year performance of Certara Inc. stock is -27.4%, while year-to-date (YTD) performance is %. CERT stock has a five-year performance of %. Its 52-week range is between 24.58 and 41.79, which gives CERT stock a 52-week price range ratio of 17.14%

Certara Inc. currently has a PE ratio of -71.00, a price-to-book (PB) ratio of 4.89, a price-to-sale (PS) ratio of 17.12, a price to cashflow ratio of 78.10, a PEG ratio of 2.32, a ROA of -4.12%, a ROC of 2.12% and a ROE of -7.28%. The company’s profit margin is -20.28%, its EBITDA margin is 32.50%, and its revenue ttm is $243.53 Million , which makes it $1.59 revenue per share.

Of the last four earnings reports from Certara Inc., there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.04 for the next earnings report. Certara Inc.’s next earnings report date is 03rd Jun 2021.

The consensus rating of Wall Street analysts for Certara Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Certara Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Certara Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Certara Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 5.22, ATR14 : 1.11, CCI20 : 35.94, Chaikin Money Flow : 0.07, MACD : 0.79, Money Flow Index : 54.43, ROC : 6.29, RSI : 25.24, STOCH (14,3) : 82.70, STOCH RSI : 1.00, UO : 53.59, Williams %R : -17.30), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Certara Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Certara Inc.

Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides proven modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines.

CEO: William F. Feehery

Telephone: +1 609 716-7900

Address: 100 Overlook Center, Princeton 08540, NJ, US

Number of employees: 899

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

News

Stocktwits